Walleye Trading’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,400
| Closed | -$179K | – | 4410 |
|
|
2025
Q2 | $179K | Buy |
+1,400
| New | +$145K | ﹤0.01% | 3299 |
|
|
2025
Q1 | – | Sell |
-1,500
| Closed | -$131K | – | 4093 |
|
|
2024
Q4 | $131K | Buy |
+1,500
| New | +$137K | ﹤0.01% | 3429 |
|
|
2024
Q3 | – | Sell |
-900
| Closed | -$97K | – | 4130 |
|
|
2024
Q2 | $97K | Sell |
900
-1,000
| -53% | -$100K | ﹤0.01% | 3383 |
|
|
2024
Q1 | $180K | Sell |
1,900
-2,800
| -60% | -$240K | ﹤0.01% | 3483 |
|
|
2023
Q4 | $434K | Buy |
+4,700
| New | +$305K | ﹤0.01% | 3199 |
|
|
2023
Q2 | – | Sell |
-8,100
| Closed | -$364K | – | 4718 |
|
|
2023
Q1 | $364K | Buy |
8,100
+3,100
| +62% | +$140K | ﹤0.01% | 3066 |
|
|
2022
Q4 | $219K | Buy |
+5,000
| New | +$240K | ﹤0.01% | 3500 |
|
|
2021
Q1 | – | Sell |
-4,300
| Closed | -$482K | – | 4820 |
|
|
2020
Q4 | $482K | Buy |
+4,300
| New | +$453K | ﹤0.01% | 2694 |
|
|
2020
Q2 | – | Sell |
-32,600
| Closed | -$1.91M | – | 4242 |
|
|
2020
Q1 | $1.91M | Buy |
32,600
+600
| +2% | +$38.6K | 0.01% | 865 |
|
|
2019
Q4 | $2.56M | Buy |
+32,000
| New | +$2.4M | 0.02% | 1019 |
|
|
2019
Q3 | – | Sell |
-900
| Closed | -$85K | – | 4036 |
|
|
2019
Q2 | $85K | Hold |
900
| – | – | ﹤0.01% | 3369 |
|
|
2019
Q1 | $72K | Buy |
+900
| New | +$66.5K | ﹤0.01% | 3605 |
|
|
2018
Q4 | – | Sell |
-8,900
| Closed | -$695K | – | 4656 |
|
|
2018
Q3 | $695K | Buy |
8,900
+4,000
| +82% | +$278K | ﹤0.01% | 2506 |
|
|
2018
Q2 | $311K | Buy |
4,900
+4,200
| +600% | +$334K | ﹤0.01% | 3258 |
|
|
2018
Q1 | $64K | Buy |
+700
| New | +$60.3K | ﹤0.01% | 4069 |
|
Other funds holding BPMC
IA
HNB
Walleye Trading's BPMC Position: Q1 2025 in Review
Walleye Trading sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 1,731 shares — an estimated $151K sold.
Walleye Trading first reported a position in BPMC in Q2 2016 and held it in 10 quarters. The position peaked at $2.03M in Q4 2023. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.
- Walleye Trading reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
- Walleye Trading sold 1,731 Blueprint Medicines shares in Q1 2025, an estimated $151K.
- Walleye Trading first reported a position in Blueprint Medicines in Q2 2016 and held it in 10 quarters.
- Walleye Trading's Blueprint Medicines position peaked at $2.03M in Q4 2023.
- 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.
Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.